Meet our
Scientific Advisory Board

A leading urologic oncologist and researcher, Dr. Aprikian graduated from the Université de Sherbrooke Medical School in 1985 and completed his urology residency training at McGill in 1990. He then pursued a three-year research and clinical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York City. In 1993, he was appointed Assistant Professor of Surgery (Urology) at McGill and began his career in prostate and bladder cancer research. In 2004, he became the Head of the Division of Urology at McGill University, a role he held until 2016. In 2007 he became Full Professor of Surgery. In 2009 he was appointed Medical Director of the McGill University Health Centre Cancer Care Mission and was jointly appointed as Professor in the McGill Department of Oncology. In 2010 he was appointed the Richard Tomlinson Chair in Prostate Cancer at McGill University. Since 2015, he has served as the Medical Director of the Cedars Cancer Centre at the MUHC.

Dr. Aprikian has been awarded the American Urologic Association Practising Urologist Award, the American Society of Clinical Oncology Young Investigator award, the McGill University William Dawson Scholar Career Award and the FRSQ Clinician Scientist Award for 12 years, reaching the Senior Scientist level. In 2004, he was a founding member of Procure, a Quebec-based prostate cancer foundation dedicated to research and public awareness and launched in 2007 a prospective longitudinal cohort study and comprehensive biobank project for prostate cancer across the province of Quebec that continues to this date. He is actively involved in a leadership role in national and provincial guidelines in cancer surgery outcomes and standards of care. He is also the President-elect of the Canadian Urology Association.